UCLA researchers have created a new system to produce human T cells, the white blood cells that fight against disease-causing intruders in the body. The system could be utilized to engineer T cells to ...

There's a small fatty gland that sits behind your sternum and is often said to be 'useless' in adulthood. A retrospective study, however, suggests the thymus gland is not nearly as expendable as ...

Immune protection fades with time, and much of that decline traces back to the thymus. This small organ, located in front of the heart, trains new T cells and releases signals that help them survive.

Scientists have mapped the thymus, a gland in the chest that makes disease-fighting white blood cells, across the human life span. This “cell atlas” could help researchers understand how thymus cells ...

Dear Doctor Roach: I have recently learned that my sibling, age 70, has rare cancer of the thymus. She will be getting chemotherapy and perhaps radiation treatment. I have heard of immunotherapy. Is ...

Please provide your email address to receive an email when new articles are posted on . Current treatments for thymic cancers did not significantly increase risk for cardiovascular disease, according ...

DUBLIN--(BUSINESS WIRE)--The "Thymus Cancer Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering. The report ...

A new preclinical model for thymic cancer has revealed insights into how a common mutation found in thymic epithelial tumors sparks their formation. The model may help speed the development of ...

As people age, their immune system function declines. T cell populations become smaller and can't react to pathogens as ...

Symptoms like shortness of breath and wheezing have become more prevalent throughout the Covid pandemic, but with other health issues, could be an early warning sign of a rare cancer of the thymus - a ...

New data highlight liver-encoded delivery of immune modulators as a strategy to mitigate age-related immune dysfunction.

Sunitinib (Sutent, Pfizer) has shown activity in the second-line treatment of thymic cancer, a disease where numerous other agents have been tested and failed. The results come from the first clinical ...